Advertisement
Screener

Nuvation Bio Inc. (NUVB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Nuvation Bio Inc. Cash Flow Breakdown

Cash flow breakdown shows where Nuvation Bio Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $173.43M went out.
  • Fiscal year ended 2025-12-31: from investing, $99.52M came in.
  • Fiscal year ended 2025-12-31: from financing, $202.53M came in.
  • Fiscal year ended 2025-12-31: change in cash, $128.36M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$173.43M$99.52M$10.11M$192.42M*$128.36M
2024-12-31-$130.41M$122.70M$4.46M*-$6.93M
2023-12-31-$68.00M$8.92M$375.00K-$58.45M
2022-12-31-$96.11M$63.46M$939.00K-$31.32M
2021-12-31-$68.19M-$454.67M$450.00K$625.08M*$102.67M
2020-12-31-$36.53M-$70.32M$133.13M*$26.29M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$42.97M*$5.99M*$3.50M*$167.03M*
2026-03-31$5.07M-$43.64M$908.00K*-$38.70M
2025-12-31-$29.73M*$87.08M*$7.71M*
2025-09-30-$52.89M*-$96.62M*$558.00K*
2025-06-30-$48.18M*$54.88M*$762.00K*$192.66M*
2025-03-31-$42.63M$54.18M$1.08M-$534.00K*$12.25M
2024-12-31-$46.30M*$51.77M*$840.00K*-$1.74M*
2024-09-30-$31.09M*$29.12M*$1.67M*-$3.21M*
2024-06-30-$37.32M*$34.27M*$1.93M*$821.00K*
2024-03-31-$15.70M$7.54M$21.00K-$8.14M
2023-12-31-$15.03M*$33.16M*$0.00*
2023-09-30-$16.16M*-$9.59M*$77.00K*
2023-06-30-$17.48M*$37.35M*$0.00*
2023-03-31-$19.33M-$52.00M$298.00K-$71.03M
2022-12-31-$16.17M*-$21.83M*$311.00K*
2022-09-30-$28.09M*$106.37M*$258.00K*
2022-06-30-$26.92M*-$15.53M*$56.00K*-$3.66M*
2022-03-31-$24.93M-$5.55M$314.00K$3.95M*-$26.22M
2021-12-31-$23.48M*-$189.26M*$230.00K*
2021-09-30-$13.15M*-$91.72M*$30.00K*
2021-06-30-$16.83M*-$172.60M*
2021-03-31-$14.73M-$1.08M$624.96M*$609.15M
2020-12-31-$12.94M*-$98.27M*$132.63M*
2020-09-30-$8.04M*$6.52M*$500.00K*
2020-06-30-$24.27M*$10.82M*
2020-03-31$8.72M$10.61M$1.89M

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Biohaven Ltd. (BHVN)United States$1.990B-3.83
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Generate Biomedicines, Inc. (GENB)United States$2.052B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B